Pricing & Reimbursment Title Chapter 5. Clinical Phase IIIA: Health Economics Activities Sub title Author Dr P C Langley Publication date January 2003 ISBN 0954112164 Pages 19 Price pdf £184   |   print n/a Summary Health Economics in the Drug Life Cycle - Chapter 5 TABLE OF CONTENTS Marketing Brochure View the marketing brochure (pdf) includes a full table of contents Pricing & Reimbursment

Dr Paul C Langley is US & International Manager, Health Economics with 3M Pharmaceuticals (USA). He has overall and worldwide responsibility for pharmacoeconomic evaluations in the Pharmaceuticals Division including supporting product development through health economics studies, preparing preliminary reimbursement submissions, managing reimbursement applications (e.g., US, UK, France, Italy), pricing evaluations and post-market entry pharmacoeconomics support. Dr Langley’s major areas of research interest are in the modelling of drug impacts within healthcare systems, the development and application of guidelines for formulary submission evaluations and the application of health economics to the process of drug development. He has published widely in pharmacoeconomics with over 50 articles, monographs and book chapters. Dr Langley has been instrumental in developing guidelines for managed care in the United States and is also one of the lead authors for the AMCP guidelines. Dr Langley is also Adjunct Professor, College of Pharmacy, University of Minnesota, and has developed an on-line training package comprising over 40 modules entitled Pharmacoeconomics on the Internet which is available through the Office of Outreach Education, College of Pharmacy, University of Minnesota.